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ABSTRACT Thyroid hormone plays an essential role in
mammalian brain maturation and function, in large part by
regulating the expression of specific neuronal genes. In this
tissue, the type 2 deiodinase (D2) appears to be essential for
providing adequate levels of the active thyroid hormone
3,5,3*-triiodothyronine (T3) during the developmental period.
We have studied the regional and cellular localization of D2
mRNA in the brain of 15-day-old neonatal rats. D2 is ex-
pressed in the cerebral cortex, olfactory bulb, hippocampus,
caudate, thalamus, hypothalamus, and cerebellum and was
absent from the white matter. At the cellular level, D2 is
expressed predominantly, if not exclusively, in astrocytes and
in the tanycytes lining the third ventricle and present in the
median eminence. These results suggest a close metabolic
coupling between subsets of glial cells and neurons, whereby
thyroxine is taken up from the blood andyor cerebrospinal
f luid by astrocytes and tanycytes, is deiodinated to T3, and
then is released for utilization by neurons.
Thyroid hormone controls a number of metabolic and devel-
opmental processes and, in particular, is an essential factor for
normal mammalian brain maturation (1). In humans and other
species, thyroid deficiency during the perinatal period results
in irreversible brain damage and mental retardation (1, 2). The
effects of thyroid hormone result primarily from changes in
gene expression mediated through the binding of the active
compound 3,5,39-triiodothyronine (T3) to specific nuclear
receptors of the steroid–retinoic acid–thyroid hormone super-
family. Previous studies have demonstrated that T3 nuclear
receptors are expressed in a complex temporal pattern in
specific regions of the brain that include the cerebral cortex,
hippocampus, striatum, cerebellum, and hypothalamus (3, 4).
These receptors are found predominantly in neurons and
oligodendrocytes (5–7), and a number of neuronal genes have
been shown to be regulated by thyroid hormone during
development (8, 9).
The majority of T3 in the brain is produced locally within the
central nervous system by the 59-deiodination of thyroxine
(T4) (10). The type 2 deiodinase (D2) appears to be of
particular importance in catalyzing the conversion of T4 to T3
in the brain during fetal and early neonatal life (11–13). During
this period in the rat, the expression of D2 activity in brain
increases at the end of gestation and is highest at 15–20 days
of postnatal life (14). This pattern of activity corresponds
temporally to the period when the developing brain is most
dependent on thyroid hormone and correlates with increasing
brain T3 concentrations, which peak at 2 weeks of age (13).
An important property of the D2 is that its activity is
markedly increased by thyroid hormone deficiency (15). This
enhanced D2 activity serves to maintain T3 production in the
brain in the face of limiting amounts of the prohormone T4
(16). Brain T3 levels thus appear to be protected to a consid-
erable extent by alterations in circulating thyroid hormone
levels (12, 16). A second important factor in this regard is a
decrease in the clearance rate of T3 in the hypothyroid brain
effected by a decrease in the activity of the type 3 deiodinase
(D3) (11). This enzyme converts T4 and T3 to inactive
metabolites by 5-deiodination (17). The coordinated regula-
tion of D2 and D3 activity appears to be critical for thyroid
hormone homeostasis in this tissue.
Complementary DNAs for the rat and human D2 have
recently been isolated and shown to code for selenoproteins,
which contain the uncommon amino acid selenocysteine at the
catalytic site (18). In the adult mammalian brain, Northern blot
analysis indicates that D2 mRNA is expressed in the cerebral
cortex, hippocampus, caudate-putamen, thalamus, and cere-
bellum (18). However, many important questions remain
unanswered concerning the expression patterns and functional
roles of the deiodinases in the central nervous system. Most
notably, only limited information is available concerning the
regional patterns of expression of the D2 during development,
and the cell type(s) that express this important enzyme have
not been identified. In the present work we demonstrate that
D2 is expressed primarily in subpopulations of glial cells in
thyroid hormone-dependent areas of the developing central
nervous system, with the highest levels of expression found in
specific regions of the hypothalamus.
METHODS
Neonatal Wistar rats (15 days old) were used in these studies.
The National Institutes of Health rules and the European
Union directives for the care and handling of animals were
followed. Northern blots were prepared using nylon mem-
branes (Nytran, Schleicher and Schuell), and hybridizations
were carried out according to standard protocols (19, 20). In
situ hybridization for the detection of D2 and neuronal-specific
enolase mRNA was performed on free-floating 25-mm sec-
tions using protocols previously described in detail (21). D2
sense and antisense riboprobes were synthesized in the pres-
ence of [35S]UTP using a 366-bp DNA template spanning
nucleotides 535–901 from the rat D2 cDNA sequence (18).
This area contains little sequence homology with the rat type
1 deiodinase (D1) and D3 mRNAs. (Attempts at using digoxi-
genin-labeled probes in these studies resulted in unacceptable
nonspecific staining.) The sections were either counterstained
with Richardson’s blue or subjected to immunohistochemistry
for glial fibrillary acidic protein (GFAP) using a polyclonal
antibody (Dako) at a 1y2,000 dilution. The atlas of Patxinos
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and Watson (22) was used for the identification of rat brain
structures.
RESULTS
In situ hybridization was performed on the brains of euthyroid
15-day-old neonatal rats, the time when D2 activity is maximal
in this tissue. The riboprobe used in these experiments spe-
cifically detected D2 mRNA, as demonstrated by Northern
analysis, by using brown adipose tissue RNA prepared from
control and cold-exposed rats (Fig. 1). Cold exposure, which
is known to induce a marked increase in brown fat D2 activity
(23), was associated with increased expression of a 7-kb major
RNA species, as well as other minor bands, as we have
previously described (18).
Representative coronal sections from different levels of the
neonatal rat brain demonstrated that D2 mRNA is expressed
in several regions. These include the olfactory bulb and
anterior olfactory nucleus (Fig. 2A), the cerebral cortex (Fig.
2 A–E), the caudate-putamen nucleus (Fig. 2 B and C), the
dorsal portion of the lateral septal nucleus (Fig. 2B), the
thalamus (Fig. 2 D and E), the hippocampus (Fig. 2 D and E),
and the hypothalamus (Fig. 2 E and F). D2 was also expressed
in the granular layer of the cerebellum as well as pontine nuclei
such as the ventral cochlear nucleus and the olivary nuclei (Fig.
2G). Lower levels of expression were found in the midbrain
(Fig. 2 H and I). Areas of white matter, such as the corpus
callosum, subcortical white matter, internal capsule, and fim-
bria of the hippocampus, were not labeled.
The distribution of D2 expression in the cerebral cortex was
not uniform; layers 1–4 showed the strongest signal, whereas
expression was low in layer 5. In the piriform cortex, expression
was noted in layer 1, whereas no signal was detected in the
neuronal layer 2. There was also some regionalization in the
caudate, with the highest expression localized to the ventro-
lateral portion of the nucleus. In the hippocampus, both the
dentate gyrus and the hippocampus proper (Ammon’s horn)
were labeled. D2 mRNA appeared to be absent from the
amygdala.
An extremely high signal was present in the hypothalamus
(Fig. 2 E and F) in the regions corresponding to the lateral
aspects of the median eminence and the lining of the lower
portion of the third ventricle (Fig. 2 E and F, arrows). This
corresponds to the known distribution of ependymal tanycytes
(24, 25), a specialized population of glial cells implicated in the
transport of hormones, and other substances in the hypothal-
amus (26). The relative amounts of D2 mRNA in the hypo-
thalamus and layers 1–4 of the parietal cortex were compared
by measuring the optical density of these regions on a low-
exposure autoradiograph (Fig. 2F). Signal strength in the
region of the third ventricle and median eminence was 4- to
5-fold higher than that in the outer layers of the cortex.
The expression pattern in the cerebral cortex was intriguing
because layer 1, which shows high D2 expression, is practically
devoid of neuronal bodies and contains mainly glial cells and
neuropile. To more precisely localize the signal to specific cell
types, we performed emulsion autoradiography and counter-
stained the sections. Fig. 3 shows corresponding dark-field and
bright-field images of several brain regions. In the olfactory
bulb (Fig. 3 A and B), D2 was expressed in the external
plexiform layer, which contains primarily glial cells and pro-
cesses. The neuron-containing mitral cell and granular layers
immediately above showed little signal. Also, the packed cells
in the subventricular layer (Fig. 3B), which was still prominent
at this age, completely lacked a hybridization signal. In the
dentate gyrus (Fig. 3 C and D), the label was present in the
molecular layer, whereas the granular cell layer of neurons was
practically devoid of signal. In Ammon’s horn (Fig. 3 C and D),
the radioactive signal was present in the stratum radiatum in
close association with the pyramidal cell layer. The pattern in
the cerebral cortex (Fig. 3 E and F) confirmed the results
obtained by macroscopic autoradiography; expression was
localized mainly to layers 1–4, with less signal in layers 5 and
6.
In the hypothalamus (Fig. 3 G and H), high expression was
present in the lining of the third ventricle (Fig. 3G, arrow) and
in a narrow rim at the lateral and basilar regions of the median
eminence (Fig. 3G, arrowhead). The inset in Fig. 3H shows a
magnification of this area under bright-field illumination. The
silver grains were concentrated immediately above the packed
cells of the pars tuberalis (arrowheads), which completely
lacked hybridization signal.
These results strongly suggested that D2 was expressed
mainly by two types of glial cells, astrocytes and tanycytes. This
was confirmed by performing in situ hybridization for D2
mRNA and immunohistochemistry with an anti-GFAP anti-
body on the same sections. Fig. 4A shows astrocytes from layer
1 of the parietal cortex. They have the typical star-like
appearance, with many long and delicate processes forming an
intricate network of fibers. The majority of silver grains were
observed over the cell processes, sometimes at a considerable
distance from the cell body. Fig. 4B shows colocalization of
silver grains with the GFAP-positive fibers crossing the mo-
lecular layer of the dentate gyrus. The distribution of D2
mRNA in the tanycytes lining the third ventricle is shown in
Fig. 4C. Silver grains were observed in both the cell bodies
(arrows) and the cellular processes (arrowheads) that cross
into the adjacent arcuate nucleus. There were also numerous
hybridization grains in the apical protrusions (blebs) of the
tanycytes. Although the periventricular location of the hypo-
thalamic D2 expressing cells indicated that they were ta-
nycytes, their identity was confirmed in other studies (data not
shown) by demonstrating intense staining of these cells for
vimentin, a tanycyte protein not found in mature astrocytes
(27).
D2 expression in the cerebellum appeared localized to the
densely packed layer of granule neurons, suggesting neuronal
expression in this region. This was further examined by in situ
hybridization using two riboprobes, an 35S-labeled D2 probe
and a digoxigenin-labeled neuronal-specific enolase probe,
which specifically labels neurons. As shown in Fig. 4D, there is
little association of silver grains with the neuronal-specific
enolase mRNA (blue spots). In contrast, immunostaining of
astrocytes with GFAP antibodies demonstrated the presence
FIG. 1. Northern blot demonstrating the specificity of the cDNA
template used for riboprobe preparation for detecting D2 mRNA.
Each lane contained 25 mg of total RNA isolated from the brown
adipose tissue of 4-week-old control rats (lanes a and b), or rats
exposed to cold (4°C) for 8 hr (lanes c and d). The position of RNA
size standards in kilobases is shown. Cy, cyclophilin.
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of D2 mRNA in these cells (Fig. 4E). Thus, expression of D2
in the cerebellum is also primarily in astrocytes.
DISCUSSION
The overall pattern of D2 mRNA expression observed in these
studies agrees well with prior reports describing the distribu-
tion of D2 activity in brain (28–30). Unlike these prior studies,
however, which relied exclusively on the determination of
59-deiodinase activity in homogenates of brain regions isolated
by gross dissection techniques, the in situ studies presented
here allow for the much more accurate, precise, and specific
localization of D2 expression.
Of importance, D2 is expressed in areas of the brain, such
as the cerebral cortex, hippocampus, caudate, and hypothal-
amus, which are known to express nuclear T3 receptors and to
be targets of thyroid hormone action during development (3,
4). For example, congenital hypothyroidism in the rat results
in marked alterations in the cytoarchitecture of the cerebral
cortex (31) as well as alterations in expression of specific genes
(8). The latter abnormality is also observed in the caudate and
the hippocampus, where thyroid hormone controls expression
of the RC3yneurogranin gene (21), whose protein product
appears to be important in long-term potentiation and mem-
ory (32). Cerebral cortical and basal ganglia abnormalities are
also observed in the human cretin, where mental retardation
and alterations of posture and movement are observed (32).
The expression of D2 in auditory relay nuclei such as the
medial geniculate, the olivary, and the ventral cochlear nuclei
suggests that these regions are also thyroid hormone respon-
sive, a finding that may be relevant to the deafness observed
in congenital hypothyroidism.
Previous studies using immunohistochemistry have reported
that T3 receptors are located in neurons and oligodendrocytes
but not in astrocytes (5–7). The finding that perinatal hypo-
thyroidism does not affect the expression of astrocytic marker
genes provides additional evidence favoring the view that
astrocytes are not target cells of thyroid hormone (33). Thus,
it was surprising to find that D2 is expressed primarily in
specific subpopulations of glial cells, namely the protoplasmic
astrocytes and tanycytes, whereas little expression appears to
occur in neurons or fibrous astrocytes of the white matter.
Several of our observations support this conclusion. For
example, cell layers containing primarily astrocytes (e.g., layer
1 of the cerebral cortex) demonstrated strong D2 mRNA
expression, whereas layers containing primarily neurons (e.g.,
the granular layer of the dentate gyrus) were devoid of staining
(Fig. 3). Furthermore, colocalization studies demonstrated
directly the presence of D2 mRNA in GFAP-positive astro-
cytes and tanycytes, with the majority of the signal being
located in the cellular processes. This latter finding is difficult
to demonstrate on some photomicrographs, given that many of
the grains are located some distance from the cell bodies in
delicate end processes that have been cut in cross-section and
lie in different planes. However, when viewed firsthand by
microscopy, which allows the processes to be traced through
the 25-mm-thick sections by altering the focus, it is readily
apparent that the grains are contained within these astrocytic
projections. These observations suggest a unique and impor-
tant role for glial cells in thyroid hormone homeostasis in the
brain.
Astrocytes serve important functions in neural biology (34,
35). Astrocytic processes ensheath synapses and thereby in-
fluence synapse formation and synaptic transmission. Glial cell
FIG. 2. In situ hybridization on sections of 15-day-old neonatal rat brain showing the regional distribution of D2 mRNA. All sections were taken
in the coronal plane at the levels of the olfactory bulb (A); the septum (B); the globus pallidus (C); the anterior hippocampus (D); the caudal
hypothalamus (E and F); the pons and cerebellum (G); and the midbrain (H) and (I). J utilized a sense probe and shows a coronal section at a
level similar to that in B. All sections were exposed for 2 weeks with the exception of F, which was exposed for 1 week. The arrow in E points to
a region of very high expression in the lower part of the third ventricle. The arrow in F points to the sharp transition in D2 expression occurring
along the lining of the third ventricle. Aq, cerebral aqueduct; AON, anterior olfactory nucleus; Ce, cerebellum; cc, corpus callosum; CPu,
caudate-putamen nucleus; Ctx, cerebral cortex; DG, dentate gyrus; GP, globus pallidus; H, hypothalamus; ic, internal capsule; LH, lateral hebenula;
LV, lateral ventricle; ME, median eminence; MG, medial geniculate nucleus; OB, olfactory bulb; ON, olivary nucleus; Pir, piriform cortex; RF,
rhinal fissure; S, septum; SC, superior collicullus; Th, thalamus; VCN, ventral cochlear nucleus; wm, white matter. Layers of the cerebral cortex
are shown in Arabic numerals.
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processes also surround capillaries and participate in the
transfer of nutrients between the blood and neurons. For
example, glucose, the main metabolic fuel used by neurons, is
actually taken up from the blood by astrocytes and processed
to lactate, which is then released for neuronal use (34). Glial
cells also play a role in maintaining brain glutamate concen-
trations (36).
A similar functional coupling between astrocytes and neu-
rons may be operative with regard to T3 production. Accord-
ing to this postulate, T4, which enters the developing brain
more easily than T3 (12), would be taken up from the
capillaries by astrocytes, deiodinated to T3, and released. This
T3 would then be available to enter neurons and interact with
T3 receptors to regulate specific neuronal functions.
Anatomic studies have demonstrated that both tanycyte
processes and the apical blebs that extend into the third
ventricle contain ribosomes and smooth endoplasmic reticu-
lum (24, 37). Thus, the localization of the D2 mRNA to
astroglial processes and blebs suggests that this microsomal
enzyme is translated and localized within these cellular com-
partments. Previous studies by Dratman and Crutchfield (38)
support the possibility that T4-to-T3 conversion may occur
within astrocytic processes, with the T3 transported to the
end-feet and released. These investigators demonstrated that
T3 derived from T4 in the brain is concentrated rapidly in
synaptosomes in which the T3:T4 ratio is 3-fold greater than in
cytosol.
The pattern of D2 mRNA in the hypothalamus strongly
suggests that this enzyme is expressed primarily in ependymal
cells, termed tanycytes. These cells are characterized by ex-
tensive processes that extend into all areas and cell groups of
the medial hypothalamus and encircle capillaries and abut on
neurons (39). Tanycytes have been implicated in the uptake
and transport of hormones and other substances into the
hypothalamus from the cerebral spinal f luid and the blood (40,
41). For example, the transport of T4 by ependymal cells from
the third ventricle into the median eminence and the portal
vessels has been demonstrated both in vivo and in organ culture
systems (42).
The finding of D2 expression in tanycytes suggests that these
cells may not only take up T4, from the cerebrospinal f luid
andyor capillaries, but also convert it to the active hormone T3
for use in various regions of the hypothalamus. This would
explain the apparent paradox that the paraventricular nucleus,
which contains thyrotropin-releasing hormone-secreting neu-
rons responsive to feedback by T4, as well as T3 (43), expresses
very little D2 activity (30). The deiodinating and transport
capacity of tanycytes thus may represent the ‘‘alternative
source of T4 monodeiodinating activity’’ postulated to exist by
Lechan and Kakucska (44). Uptake of T4 from the cerebro-
spinal f luid, with its subsequent deiodination to T3 and
transport to the median eminence and the portal system, could
also influence pituitary function. Alternatively, T4 could be
taken up from the fenestrated vessels of the median eminence,
deiodinated, and the T3 transported to the cerebrospinal f luid.
Indeed, bidirectional transport of substances by tanycytes
between the third ventricle and the vascular compartment has
been demonstrated (45).
To date, studies localizing D1 and D3 expression to specific
cell types in the brain have not been reported. The D1 is also
a 59-deiodinase that converts T4 to T3 and, if present in
neurons, could be an alternative source of T3 for these cells.
However, only limited information is available in the literature
on the pattern of 59-deiodinase expression in the developing
rat brain (14, 29), and the techniques employed in these studies
have not allowed the accurate determination of D1 activity.
However, ongoing studies have demonstrated that D1 activity,
though detectable, is minimal in the cerebral cortex of neo-
natal rats (J. Bates and V. A. Galton, personal communica-
tion). This observation, along with the known poor efficiency
with which D1 utilizes T4 (as compared with reverse T3) as a
substrate for 59-deiodination, makes it unlikely that this iso-
FIG. 3. Dark- and bright-field images showing the distribution of silver grains after coating the hybridized sections with photographic emulsion.
The sections were exposed for 20 days. Sections shown correspond to the main olfactory bulb [dark field (A); bright field (B)], the dentate gyrus
[dark field (C); bright field (D)], the somatosensory cortex [dark field (E); bright field (F)], and the hypothalamus at the level of the median
eminence and arcuate nucleus (dark field (G); bright field (H)]. Arc, arcuate nucleus; bv, blood vessel; epl, external plexiform layer; Gr, granular
cell layer; ir, infundibular recess; ME, median eminence; mcl, mitral cell layer; mol, molecular layer; PT, pars tuberalis; pyr, pyramidal cell layer
(CA1 field); sr, stratum radiatum; svl, subventricular layer; wm, white matter. In G the arrow points to the ventricular lining and the arrowhead
points to an extremely high signal above the pars tuberalis. The corresponding bright-field image is shown in the Inset of H, with black arrowheads
pointing to the silver grains of the photographic emulsion. Photomicrographs were taken with a 53 objective. (Bars 5 200 mm.)
10394 Neurobiology: Guadano-Ferraz et al. Proc. Natl. Acad. Sci. USA 94 (1997)
form contributes significantly to the neuronal pool of T3 in the
neonatal brain.
In summary, our observations suggest that astroglial cells
play a central role in thyroid hormone homeostasis in the
developing central nervous system and may modulate neuronal
and oligodendrocyte function through the production and
release of T3. This concept raises the intriguing possibility that
neuronal processes might influence astroglial D2 activity
through local regulatory mechanisms. In this context, the
demonstrated effects of adrenergic agents and other sub-
stances to stimulate D2 activity in primary cultures of rat
neonatal astroglial cells may be of relevance (46–48).
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